title: Treatment of chloroquine-resistant falciparum malaria with a combination of quinine, quinidine and cinchonine (LA40221) in adults by oral and intravenous administration.
authors.forename: D
authors.initials: D
authors.lastname: Bunnag
authors.forename: T
authors.initials: T
authors.lastname: Harinasuta
authors.forename: S
authors.initials: S
authors.lastname: Vanijanonta
authors.forename: S
authors.initials: S
authors.lastname: Looareesuwan
authors.forename: S
authors.initials: S
authors.lastname: Chittamas
authors.forename: W
authors.initials: W
authors.lastname: Punnavut
authors.forename: J
authors.initials: J
authors.lastname: Berth
authors.forename: P
authors.initials: P
authors.lastname: Druilhe
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage* / Q000627:therapeutic use; D002930:Cinchona Alkaloids / Q000008:administration & dosage* / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D007262:Infusions, Intravenous; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum; D011802:Quinidine / Q000008:administration & dosage* / Q000627:therapeutic use; D011803:Quinine / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000962:Antimalarials; D002930:Cinchona Alkaloids; D004338:Drug Combinations; D011803:Quinine; D011802:Quinidine; C010086:cinchonine